Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phagocyte NADPH oxidase (NOX2) complex is the primary enzymatic machinery responsible for the respiratory burst in neutrophils, a process essential for innate immunity (Bedard & Krause, 2007). This multicomponent system consists of the membrane-bound cytochrome b558 (composed of gp91phox and p22phox) and several cytosolic subunits (p47phox, p67phox, p40phox, and the small GTPase Rac) that assemble at the phagosomal or plasma membrane upon activation (Panday et al., 2015). Its main function is to catalyze the transfer of electrons from NADPH to molecular oxygen, generating superoxide anions, which serve as precursors for other microbicidal reactive oxygen species (ROS) like hydrogen peroxide and hypochlorous acid (Lambeth, 2004). While crucial for pathogen killing, excessive or chronic activation of this machinery contributes to tissue injury in inflammatory, cardiovascular, and neurodegenerative diseases (Roos et al., 2003). Conversely, genetic deficiencies in any of the NOX2 subunits lead to Chronic Granulomatous Disease (CGD), a primary immunodeficiency characterized by life-threatening infections and granuloma formation (StatPearls, 2023). Therapeutic strategies targeting this machinery focus on small-molecule inhibitors to dampen oxidative stress in chronic inflammation, though maintaining a balance to avoid immunosuppression remains a significant challenge.
Inhibition of the enzymatic conversion of molecular oxygen to superoxide anions by blocking electron transfer within the NOX2 complex or preventing the assembly of its cytosolic and membrane-bound subunits.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagocyte NADPH oxidase complex (NOX2).